Ivaltinostat (CG-200745) is an orally active pan-HDAC inhibitor that inhibits deacetylation of histone H3 and tubulin; induces p53 accumulation, promotes p53-dependent transactivation, and enhances expression of MDM2 and p21(Waf1/Cip1) proteins; sensitizes gemcitabine-resistant cells to gemcitabine and 5-fluorouracil (5-FU); induces apoptosis and exhibits antitumor activity.